Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Voso, Maria Teresa  [Clear All Filters]
2023
Travaglini S, Gurnari C, Antonelli S, Marchesi F, De Angelis G, Ottone T, Divona M, Cristiano A, Hajrullaj H, Mengarelli A, et al. Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept. Br J Haematol. 2023.
Gurnari C, Robin M, Godley LA, Drozd-Sokołowska J, Włodarski MW, Raj K, Onida F, Worel N, Ciceri F, Carbacioglu S, et al. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. Lancet Haematol. 2023.
Guarnera L, Santinelli E, Galossi E, Cristiano A, Fabiani E, Falconi G, Voso MTeresa. Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions. Exp Hematol. 2023.
Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MTeresa, Cerretti R, et al. Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M. Leukemia. 2023.
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao L-P, Berrocal JCarlos Cab, Sala C, Maggioni G, Bernardi M, et al. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. J Clin Oncol. 2023:JCO2201784.
2021
Buccisano F, Palmieri R, Piciocchi A, Arena V, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, et al. ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. Blood Adv. 2021.
Trinh BQ, Ummarino S, Zhang Y, Ebralidze AK, Bassal MA, Nguyen TMinh, Heller G, Coffey R, Tenen DE, van der Kouwe E, et al. Myeloid lncRNA LOUP Mediates Opposing Regulatory Effects of RUNX1 and RUNX1-ETO in t(8;21) AML. Blood. 2021.
2019
Masciarelli S, Capuano E, Ottone T, Divona M, Lavorgna S, Liccardo F, Śniegocka M, Travaglini S, Noguera NI, Picardi A, et al. Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML. Blood Adv. 2019;3(24):4155-4160.
Falconi G, Fabiani E, Criscuolo M, Fianchi L, Finelli C, Cerqui E, Pelosi E, Screnci M, Gurnari C, Zangrilli I, et al. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome. Leuk Res. 2019;84:106191.
2018
Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Rossi ELLindfors, Finelli C, Cerqui E, Ottone T, Molteni A, et al. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. Leukemia. 2018.
2015
Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CSpertilli, Bellesi S, Hohaus S, Voso MTeresa, D'Alò F, Leone G. Impairment of PI3K-AKT and WNT-β catenin pathways in bone marrow mesenchymal stem cells isolated from patients with Myelodysplastic Syndromes. Exp Hematol. 2015.